XenoPort, Inc. (XNPT) - NASDAQ
From other sites
Company Description
XenoPort, Inc. is a biopharmaceutical company focused on developing and commercializing a portfolio of internally discovered product candidates for the potential treatment of neurological disorders. The company's first product gabapentin enacarbil which is known as Horizant in United States and... More
Sector: Healthcare
Industry: Biotechnology
Country: United States